Legal Advantage Investments Inc. Invests $358,000 in GRAIL, Inc. $GRAL

Key Points

• Legal Advantage Investments Inc. has acquired 14,000 shares of GRAIL, Inc. (NASDAQ:GRAL), valued at approximately $358,000, during the first quarter.
• GRAIL's stock recently reported a 5.3% decline and has a current market cap of $1.16 billion, with a significant twelve-month trading range of $12.33 to $63.99.
• Insider transactions include CFO Aaron Freidin selling 8,000 shares and major shareholder Chun R. Ding selling 339,800 shares, indicating notable trading activity among company insiders.

Legal Advantage Investments Inc. bought a new stake in GRAIL, Inc. (NASDAQ:GRAL - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 14,000 shares of the company's stock, valued at approximately $358,000.

Other large investors have also recently made changes to their positions in the company. State of Tennessee Department of Treasury acquired a new position in shares of GRAIL in the 4th quarter valued at $28,000. Caldwell Sutter Capital Inc. acquired a new position in shares of GRAIL in the 1st quarter valued at $28,000. Sterling Capital Management LLC acquired a new position in shares of GRAIL in the 4th quarter valued at $29,000. KBC Group NV increased its holdings in GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock worth $37,000 after acquiring an additional 933 shares in the last quarter. Finally, S.A. Mason LLC increased its holdings in GRAIL by 50.1% in the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock worth $38,000 after acquiring an additional 500 shares in the last quarter.

Insider Activity

In other news, CFO Aaron Freidin sold 8,000 shares of the business's stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total transaction of $311,440.00. Following the transaction, the chief financial officer owned 286,020 shares of the company's stock, valued at approximately $11,134,758.60. The trade was a 2.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Joshua J. Ofman sold 9,692 shares of the business's stock in a transaction dated Monday, June 30th. The shares were sold at an average price of $52.00, for a total transaction of $503,984.00. Following the transaction, the president directly owned 492,076 shares in the company, valued at approximately $25,587,952. The trade was a 1.93% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 357,492 shares of company stock valued at $17,645,718.

GRAIL Stock Down 4.2%

Shares of GRAIL stock traded down $1.38 during trading hours on Tuesday, reaching $31.42. 572,889 shares of the company's stock were exchanged, compared to its average volume of 1,364,116. GRAIL, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The company has a market capitalization of $1.13 billion, a P/E ratio of -2.40 and a beta of 3.26. The business has a fifty day moving average of $39.97 and a two-hundred day moving average of $36.35.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The firm had revenue of $35.54 million for the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. As a group, research analysts predict that GRAIL, Inc. will post -15.15 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group boosted their price target on shares of GRAIL from $32.00 to $43.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, GRAIL currently has a consensus rating of "Hold" and an average price target of $31.50.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.